ArticleInternational journal of breast cancer2022

Cost and Clinical Benefits Associated with Oncotype DX® Test in Patients with Early-Stage HR+/HER2- Node-Negative Breast Cancer in the Netherlands.

Felix E de Jongh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.